UNSPSC 51453104: Morantel pamoate

This classification denotes an antihelminthic agent with the molecular formula C23H16O6.C12H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J33H52K3OO, chemically known as pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)vinyl)-, 4,4'-methylenebis(3-hydroxy-2-naphthoate, (e)-, but more generally known as morantel pamoate, which bears US NIH Compound Identifier 6435816.

European Medicines Agency schedules morantel pamoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09063MIG. Most nations, for tariff purposes, schedule morantel pamoate under HS 29349990. SMILES: CC1CCSC1/C=C/C2=NCCCN2C.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O.

UNSPSC 51453104 Morantel pamoate, a Commodity code, nominally addresses a specific antiparasitic pharmaceutical active ingredient, but recent state and local solicitation activity tagged to this code shows little alignment with the code's narrowly defined scope. The two recorded opportunities—an Illinois Department of Public Health pharmaceutical warehouse piggyback contract awarded to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida IFB for Naloxone and drug deactivation systems—are unrelated to Morantel pamoate specifically. State and local procurement offices do solicit pharmaceuticals through cooperative purchasing vehicles and direct IFBs, and issuing bodies include state health departments, county health authorities, and specialized health districts, but the recorded opportunities in this code's recent history do not reflect a sustained procurement stream for Morantel pamoate itself.

Geographic activity and available recent opportunities provide limited signal for business development. The two tagged opportunities span Illinois and Florida, with the Illinois contract representing an awarded MMCAP Infuse cooperative-purchasing piggyback closed on August 28, 2026, and the Seminole County opportunity released as an IFB on June 30, 2026, with a response deadline of July 26, 2023—a date in the past relative to the present date of October 20, 2026. The code shows minimal recent relevant activity; firms targeting Morantel pamoate sales to state and local health systems should monitor broader pharmaceutical procurement codes and track cooperative purchasing vehicles such as MMCAP Infuse directly rather than rely on this Commodity code for solicitation signals.